"10.1371_journal.pone.0012117","plos one","2010-08-12T00:00:00Z","Bénédicte Menn; Stéphane Bach; Teri L Blevins; Mark Campbell; Laurent Meijer; Serge Timsit","Neurokin S.A., Institut de Neurobiologie de la Méditerranée, Marseille, France; USR3151, CNRS, Station Biologique de Roscoff, Roscoff, France; Efficacy Pharmacology, MDS Pharma Services, Bothell, Washington, United States of America; Département de Neurologie, CHRU Brest, Faculté de Médecine et des Sciences de la Santé de Brest, Brest, France","Conceived and designed the experiments: BM ST. Performed the experiments: BM SB TLB MC. Analyzed the data: BM SB MC lM ST. Contributed reagents/materials/analysis tools: lM. Wrote the paper: BM ST.","The authors declare financial competing interests. BM and ST are Neurokin S.A. shareholders. LM is ManRos S.A.S shareholder. ST received consultant fees from Neurokin S.A. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials.","2010","08","Bénédicte Menn","BM",6,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
